These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15283134)

  • 21. Information for patients. I have HER2 positive metastatic breast cancer: is my treatment working?
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):48a-48b. PubMed ID: 19856610
    [No Abstract]   [Full Text] [Related]  

  • 22. New oncology strategy: molecular targeting of cancer cells.
    Capriotti T
    Medsurg Nurs; 2004 Jun; 13(3):191-5. PubMed ID: 15219169
    [No Abstract]   [Full Text] [Related]  

  • 23. New approaches in the management of lung cancer.
    Kris M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S22-4. PubMed ID: 16280107
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibody therapy in hematology and oncology - part 1].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversing resistance to targeted therapy.
    Vidal L; Attard G; Kaye S; De Bono J
    J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls.
    Brandes AA; Franceschi E; Tosoni A; Degli Esposti R
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):179-84. PubMed ID: 20131994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone targeted therapy in breast cancer: present and future.
    Huober J; Thürlimann B
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S7-10. PubMed ID: 20427030
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeted cancer therapeutics: the heartbreak of success.
    Mann DL
    Nat Med; 2006 Aug; 12(8):881-2. PubMed ID: 16892027
    [No Abstract]   [Full Text] [Related]  

  • 29. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-drug conjugates for cancer: poised to deliver?
    Hughes B
    Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoclonal antibodies in cancer therapy: 25 years of progress.
    Oldham RK; Dillman RO
    J Clin Oncol; 2008 Apr; 26(11):1774-7. PubMed ID: 18398141
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 33. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimizing the delivery of targeted research: an opportunity for comparative effectiveness research.
    Pritchard KI
    J Clin Oncol; 2010 Mar; 28(7):1089-91. PubMed ID: 20124174
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibody treatment of solid tumors: a coming of age.
    Murray JL
    Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates.
    Huennekens FM
    Trends Biotechnol; 1994 Jun; 12(6):234-9. PubMed ID: 7765070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rollercoaster ride to anti-cancer antibodies.
    Weiner LM; Carter P
    Nat Biotechnol; 2003 May; 21(5):510-1. PubMed ID: 12721576
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting tumors with nanobodies for cancer imaging and therapy.
    Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
    J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions.
    Ahluwalia MS; Wen PY
    Expert Rev Anticancer Ther; 2011 May; 11(5):653-6. PubMed ID: 21554035
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development of monoclonal antibody therapy for brain tumors].
    Mishima K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():569-77. PubMed ID: 16201583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.